Stay updated on Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded 'Revision: v3.3.3'. Removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe changes are administrative updates to the study record history, adding Revision: v3.3.2 and removing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoval of an administrative notice about government funding and operating status. It does not affect the study record content.SummaryDifference0.8%

- Check67 days agoChange DetectedNew entries were added to the version history showing recruitment/status updates across versions, and the history table now lists version dates and the specific changes for each version.SummaryDifference0.1%

- Check89 days agoChange DetectedVersion bump to v3.2.0 accompanied by a government-operating-status notice; replaces the earlier v3.1.0 tag.SummaryDifference13%

- Check96 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. No other content changes observed.SummaryDifference0.3%

Stay in the know with updates to Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.